TENXIMA MF: Dual-Action Hemostatic and Analgesic Therapy with Tranexamic Acid (500mg) and Mefenamic Acid (250mg).

TENXIMA MF

Tranexamic Acid (500mg), and Mefenamic Acid (250mg) Tablet

TENXIMA MF combines Tranexamic Acid (500mg) and Mefenamic Acid (250mg) to provide comprehensive relief from excessive bleeding and associated pain. This dual-action formulation is designed to address the needs of individuals experiencing heavy menstrual bleeding, ensuring effective hemostatic control while also providing pain relief.

Key Ingredients in TENXIMA MF:

1. Tranexamic Acid (500mg): An antifibrinolytic agent that helps to prevent excessive bleeding by inhibiting the activation of plasminogen to plasmin, thereby stabilizing blood clots.
2. Mefenamic Acid (250mg): A nonsteroidal anti-inflammatory drug (NSAID) that provides analgesic and anti-inflammatory effects, reducing pain and inflammation associated with menstrual cramps and other conditions.

Mechanism of Action:

• Tranexamic Acid: Inhibits the activation of plasminogen to plasmin, preventing the breakdown of fibrin clots and reducing excessive bleeding.
• Mefenamic Acid: Inhibits the enzyme cyclooxygenase (COX), which is involved in the production of prostaglandins. Prostaglandins are chemicals in the body that cause inflammation, pain, and fever. By reducing prostaglandin levels, Mefenamic Acid alleviates pain and inflammation.

Indications:

• Heavy Menstrual Bleeding (Menorrhagia): TENXIMA MF is effective in reducing menstrual blood loss and alleviating menstrual pain.
• Dysmenorrhea (Menstrual Cramps): Provides relief from the pain and discomfort associated with menstrual cramps.
• Other Conditions with Excessive Bleeding and Pain: Can be used in other scenarios where both bleeding control and pain relief are needed, as advised by a healthcare provider.

Dosage and Administration:

• For Heavy Menstrual Bleeding and Dysmenorrhea: The typical dosage is one tablet of TENXIMA MF taken three times a day during menstruation for up to 5 days or as directed by a healthcare provider.
• The exact dosage may vary based on individual needs and the severity of symptoms, and should be determined by a healthcare provider.

Side Effects:

• Common: Nausea, vomiting, diarrhea, abdominal pain, dizziness, headache, and gastrointestinal disturbances.
• Less Common: Skin rash, itching, and swelling.
• Serious: Visual disturbances, thrombosis (blood clots), gastrointestinal bleeding, and severe allergic reactions.

Precautions:

• Thromboembolic Risk: Use with caution in patients with a history of thromboembolic disease such as deep vein thrombosis (DVT), pulmonary embolism (PE), or stroke.
• Renal Impairment: Dosage adjustments may be necessary in patients with renal impairment to avoid accumulation and toxicity.
• Gastrointestinal Conditions: Patients with a history of gastrointestinal ulcers or bleeding should use TENXIMA MF with caution.
• Allergies: Patients with known hypersensitivity to Tranexamic Acid, Mefenamic Acid, or other NSAIDs should avoid using TENXIMA MF.

Monitoring:

• Visual Monitoring: Monitor for any visual disturbances, and discontinue use if any visual changes occur.
• Thrombosis Monitoring: Regular monitoring for signs of thrombosis is recommended, especially in patients with a history of thromboembolic events.
• Gastrointestinal Monitoring: Monitor for symptoms of gastrointestinal bleeding, such as black or bloody stools or vomiting blood.

Conclusion:

TENXIMA MF offers a dual-action approach to managing heavy menstrual bleeding and associated pain by combining Tranexamic Acid and Mefenamic Acid. This formulation provides effective hemostatic control while also alleviating pain and inflammation. By stabilizing blood clots and reducing pain, TENXIMA MF enhances the quality of life for individuals experiencing heavy menstrual bleeding and dysmenorrhea. Healthcare providers should tailor dosages to individual patient needs and monitor for potential side effects to ensure safe and effective use. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. gynecology, Pediatrics, Dental care, and Dermatology.The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW